# Glyxambi 10 mg/5 mg filmom obalené tablety · TBL FLM · 100



## Slovakia

- **ŠÚKL** — [sk.dose-10060.org](https://sk.dose-10060.org)

## Codes

- **sk-sukl** — `1963C`
- **sk-registration** — `EU/1/16/1146/009`
- **eu-number** — `EU/1/16/1146/009`

## Status

- **registered_on** — 2016-11-11
- **renewal_applied** — False
- **status** — registered
- **unlimited** — True
- **read** — 2026-11-15T03:39:40Z

## Holder

- Boehringer Ingelheim International GmbH

## Proof

Record sk:presentation:sukl:1963C version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Glyxambi 10 mg - 5 mg](https://dosidal.ai/pack/be/510160-01) — BE — same product (EU central number)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219136) — CZ — same product (EU central number, substance code published by the source, with strength and form as published)
- [Glyxambi](https://dosidal.ai/pack/eu/EU-1-16-1146-009) — EU — same product (EU central number)
- [GLYXAMBI 10 MG/5 MG FILMTABLETTA](https://dosidal.ai/pack/hu/210803787) — HU — same product (EU central number)
- [Glyxambi](https://dosidal.ai/pack/pl/05909991308629) — PL — same product (EU central number)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219128) — CZ — same substance, strength and form (substance code published by the source, with strength and form as published)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219129) — CZ — same substance, strength and form (substance code published by the source, with strength and form as published)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219130) — CZ — same substance, strength and form (substance code published by the source, with strength and form as published)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219131) — CZ — same substance, strength and form (substance code published by the source, with strength and form as published)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219132) — CZ — same substance, strength and form (substance code published by the source, with strength and form as published)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219133) — CZ — same substance, strength and form (substance code published by the source, with strength and form as published)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219134) — CZ — same substance, strength and form (substance code published by the source, with strength and form as published)
- [GLYXAMBI](https://dosidal.ai/pack/cz/0219135) — CZ — same substance, strength and form (substance code published by the source, with strength and form as published)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
